PEG-interferon-alpha-2b and ribavirin treatment in children and adolescents with chronic hepatitis C

被引：0
|
作者：
Wirth, S
Ballauff, A
Kullmer, U
Lang, T
Wintermeyer, P
Gerner, P
机构：
[1] HELIOS Klinikum, Wuppertal, Germany
[2] Univ Essen Gesamthsch, Childrens Hosp, Essen, Germany
[3] Univ Mainz, Childrens Hosp, D-6500 Mainz, Germany
[4] Childrens Hosp Univ, Munich, Germany
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：344A / 344A
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS ANALYSIS OF PEG-INTERFERON ALPHA-2A PLUS RIBAVIRIN VERSUS CONVENTIONAL INTERFERON ALPHA-2A PLUS RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C IN CHINA
    Chen, W.
    Wei, L.
    VALUE IN HEALTH, 2011, 14 (07) : A280 - A280
  • [42] Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients
    El-Zayadi, A
    Selim, O
    Haddad, S
    Simmonds, P
    Hamdy, H
    Badran, HM
    Shawky, S
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (06): : 472 - 475
  • [43] Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents
    Al Ali, Jaber
    Owayed, Salem
    Al-Qabandi, Wafa'a
    Husain, Khaled
    Hasan, Fuad
    ANNALS OF HEPATOLOGY, 2010, 9 (02) : 156 - 160
  • [44] High dose consensus interferon in nonresponders to interferon alpha-2b and ribavirin with chronic hepatitis C
    Moskovitz, DN
    Manoharan, P
    Heathcote, EJ
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 17 (08): : 479 - 482
  • [45] Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatitis C in HIV patients
    Cargnel, A
    Angeli, E
    Mainini, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, P
    GASTROENTEROLOGY, 2003, 124 (04) : A766 - A766
  • [46] Interferon alpha-2b plus ribavirin for chronic hepatitis C in primary nonresponders to interferon alone
    Demir, K
    Kaymakoglu, S
    Dincer, D
    Tuncer, I
    Durakoglu, Z
    Karaca, C
    Besisik, F
    Cakaloglu, Y
    Okten, A
    JOURNAL OF HEPATOLOGY, 2001, 34 : 171 - 171
  • [47] Treatment of chronic hepatitis C in HIV infected patients (pts) with pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b
    Cargnel, A
    Angeli, E
    Mainini, A
    Casella, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, PG
    JOURNAL OF HEPATOLOGY, 2003, 38 : 132 - 132
  • [48] Risk score based PEG Interferon alpha 2b and Ribavirin treatment response estimation model for genotype 1 chronic hepatitis C patients
    Jurczyk, K.
    Laurans, L.
    Karpinska, E.
    Wawrzynowicz-Syczewska, M.
    Parczewski, M.
    Boron-Kaczmarska, A.
    ADVANCES IN MEDICAL SCIENCES, 2011, 56 (02): : 165 - 171
  • [49] A randomized prospective clinical trial comparing pegylated interferon alpha 2a/ribavirin versus pegylated interferon alpha 2b/ribavirin in the treatment of Chronic Hepatitis C
    Sinha, S
    Gulur, P
    Patel, V
    Hage-Nassar, G
    Tenner, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S77 - S78
  • [50] Ribavirin and interferon alpha-2b combination treatment of chronic hepatitis C is effective in patients with clotting disorders
    Fried, R
    Meili, E
    Peter, K
    Hartmann, S
    Tsakiris, D
    Egger, H
    Marbet, G
    GASTROENTEROLOGY, 2001, 120 (05) : A382 - A383
12345